We service Residential & Commercial facilities. Our services offer Air ducts cleaning, Dryer vent cleaning, carpet cleaning and H-VAC maintenance. We have a variety of products we offer to improve your indoor air environment and will help you to reduce energy costs. For more information you can check our website and get as much information about our services. If you are a business or a home owner we be happy to provide you with variety of solutions to you how to save on energy costs and improve your indoor air quality. we service all San Diego County, and bring with us 15 plus years of experience in this industry. We will be more than happy to assist you in any way we can help or refer you to other professional we affiliate with.
We service Residential & Commercial facilities. Our services offer Air ducts cleaning, Dryer vent cleaning, carpet cleaning and H-VAC maintenance. We have a variety of products we offer to improve your indoor air environment and will help you to reduce energy costs. For more information you can check our website and get as much information about our services. If you are a business or a home owner we be happy to provide you with variety of solutions to you how to save on energy costs and improve your indoor air quality. we service all San Diego County, and bring with us 15 plus years of experience in this industry. We will be more than happy to assist you in any way we can help or refer you to other professional we affiliate with.
ECRI’s horizon scanning efforts enable healthcare decision makers to stay informed about new and emerging technologies, innovations, and trends occurring across healthcare. We use a systematic scanning process to scan for and identify potentially disruptive innovations up to three years before clinical availability outside of the research environment. The horizon scanning team evaluates each innovation's potential to impact patient and population health outcomes, health disparities, health care costs, infrastructure needs, and many other factors to detect signals of the innovation's potential to disrupt—positively or negatively—the current state of healthcare.
Today HCA Healthcare UK is the largest private healthcare provider in the world, and the largest provider of privately funded healthcare in the UK. A world-class network of over 30 facilities in London, Manchester, Wilmslow, Glasgow and Prestatyn, with its latest venture opening in Birmingham in 2023. Uniquely we also partner with the NHS to provide care within large NHS teaching hospitals. No other UK provider can match our global scale, breadth and depth of knowledge and expertise.We treat 27 million people each year across our global network, and many of our hospitals are rated ‘Outstanding’ by the CQC. Covering virtually all aspects of medicine from prevention and diagnosis through to treatment and aftercare in both our Primary and Secondary Care Divisions. Cardiac and Cancer Care, Paediatrics, Orthopaedics, Rehabilitation, Urgent Care, GP and Health screening to Obstetrics, IVF and Maternity care, to name a few.
CityVibe is here to simplify your life, so you can spend less time worrying about real estate and more time living. As experienced real estate professionals, we buy and sell property across the nation with the primary intent of creating positive outcomes for people in predicaments.Our job is to make your life easier, and because we are investors, we have the flexibility to offer you multiple solutions when buying and selling property.
We are a workforce of over 11,000 who strive to offer world-class healthcare focused on realising our vision of healthier communities, achieved together.Te Whatu Ora Te Toka Tumai Auckland plays a unique national and regional role as a centre of excellence providing health and wellbeing services to 545,000 who live in our district as well as offering 19 national specialist healthcare services to all of New Zealanders, which includes transplants, high risk obstetrics and some paediatric services.We have an international reputation and are renowned academically as New Zealand’s largest teaching hospital. We hold an alliance with the University of Auckland and its Faculty of Medical and Health Sciences in the form of the Auckland Academic Health Alliance. This patient-centred partnership has the purpose of speeding up the translation of research ‘from the bench to the bedside’, aiding the development of our health workforce, informing research strategy and stimulating clinical teaching to ensure scientific breakthroughs and advances in medical care reach patients faster, giving our passionate clinicians the opportunity to be at the forefront of driving advancements in their chosen fields.We have three major facilities Auckland City Hospital, Starship Children’s Hospital and Greenlane Clinical Centre. Auckland City Hospital is New Zealand’s largest public hospital as well as the largest clinical research facility (with over 1000+projects at any given time), playing a key role in advancing national and international research. We have approximately one million patient contacts each year, including hospital and outpatient services. But, Te Whatu Ora Te Toka Tumai Auckland is more than hospitals with our principal purpose being to maxmise the health and wellbeing of our people, with 93% of our population reporting good, very good or excellent health. Life expectancy is a good overall measure of population health status and we have one of the highest life expectancies of any Health New Zealand region in the country at 82.9 years. Life expectancy for our Māori population has increased by nearly five years over the last decade. We are the fourth largest, and one of the fastest growing Health New Zealand region in the country, expecting more than 98,000 extra people by 2025.
With two main hospital sites in Leer- and Weener-City-Centre and a satellite unit on Borkum-Island, Klinikum Leer is a 400+ bed University teaching hospital (MHH Hannover), which provides primary and secondary health services to the people of the east-frisian area. We care for 19.000 inpatients and 50.000 outpatients per year in 15 departments (internal medicine/ gastroenterology, cardiology and angiology, pneumology, geriatrics, spinal surgery, vascular surgery, abdominal surgery, trauma surgery and orthopedics, pediatrics, gynecology/obstetrics, psychosomatic medicine and psychotherapy, ophthalmology, anesthesia/intensive medicine, radiology).
We offer California’s largest selection of forested siding, flooring, fencing, reclaimed American barnwoods, authentic hand-hewn beams, exotic hardwoods and live-edge slabs, veneers in over 200+ species. At RWOW, we’re passionate about stunning, eco-friendly wood products. We actively source an array of reclaimed, sustainable and environmentally conscious woods from around the world. Our large inventory and decades of experience allow us to service projects of all sizes. From large-scale commercial to single-family residential, we’re passionate about providing our clients with the perfect wood products for the job.
Calico is a Bay Area research and development company whose mission is to harness advanced technologies to increase our understanding of the biology that controls lifespan. We use that knowledge to devise interventions that enable people to lead longer and healthier lives. We’re working in mostly uncharted areas rooted in biology and advanced technology. Executing on this mission will require an unprecedented level of interdisciplinary effort and a long-term focus for which funding is already in place. Calico employees are scientists, engineers, explorers and inventors, comfortable with the knowledge that often incremental steps lead to a giant leap.
Four Research PostDoctoral Positions at University of Parma (IT). Four postdoctoral positions are available at the TecMedLab at the Department of Medicine and Surgery at the University of Parma (Parma, IT) in the group of Prof. Michele Miragoli. The TecMedLab research activity is dedicated to understanding the mechanisms underlying arrhythmias and to finding possible therapies using nanomaterials. The present 3-year project aims to realize a platform for producing cardiac organoids-on-a-chip from differentiated human iPSC, for High Throughput Functional and Molecular screenings. The Project will take advantage of a collaboration with the Department of Engineering and Architecture and the Department of Chemical Science (Prof. Nicola Delmonte), Life Science and Environmental Sustainability (Prof. Barbara Montanini).We are now looking for four motivated postdocs with excellent interpersonal and team skills with the following characteristics: PD 1. Engineer with <5 yrs from the Ph.D. VIVA date, with experience in sensors, IoT, electronics, programming and computer vision technologies. At least one paper as the first author in an internationally recognized peer-review journal. Knowledge of LabView/Matlab/Python software programming will be a plus. PD 2. Bioinformatician with <5 yrs from the Ph.D. VIVA date. Candidates are required experience in NGS data analysis especially for transcriptomics (both bulk and micro RNA), bash/Python/R programming and a strong background in molecular biology are also requisites. At least one paper as the first author in an internationally recognized peer-review journal. Although not strictly necessary, experience in nanomedicine and/or in single-cell sequencing approaches would be given favorable consideration. PD 3. Cellular biologist or Bioengineer with <5 yrs from the Ph.D. VIVA date. At least one paper as the first author in an internationally recognized peer-review journal. Experience with organoids made by hiPSC reprogramming and differentiation is mandatory. Knowledge of 3D bioprinting, microscopy and nanomedicine and/or computer programming will be a plus. PD 4. Cardiac Physiologist or Bioengineer with <5 yrs from the Ph.D. VIVA date, with experience in cardiac signals analysis and classification with artificial intelligence. At least one paper as the first author in an internationally recognized peer-review journal. In-vitro and in-vivo electrical and optical mapping experience will be highly appreciated. English communication skills are mandatory for all 4 PD, and experience abroad is particularly valued. Positions are for 1 year, renewable for the other two years. Starting month: June 2022. Salaries will be based on experience (Assegno di Ricerca UNIPR Spin point 1-5, from 23.788 to 35.000 per annum). Please note that two out of four positions are dedicated to non-Italian citizens or Italian citizens that did not work in Italy for more than 12 months in the past three years. Please also note that all foreigners and Italian citizens that worked abroad for at least two years can benefit from tax exemption schemes. Candidates are advised to apply as early as possible as the selection and interview process will commence immediately and will end as soon as the right candidate has been found. Interested candidates should send their CV’s, a brief statement of research and career interest, and at least two names of references with contact information to: michele.miragoli@unipr.it References Papers:Lagonegro, P., Rossi, S., Salvarani, N., Lo Muzio, FP, Rozzi G., Modica J, Bigi F., Quaretti M., Salviati G., Pinelli S., Alinovi R., Catalucci D., D’Autilia F., Gazza F., Condorelli G., Miragoli M. Synthetic recovery of impulse propagation in myocardial infarction via silicon carbide semiconductive nanowires. Nat Commun 13, 6 (2022). https://doi.org/10.1038/s41467-021-27637-2 M. Miragoli, P.Ceriotti, M.Iafisco, M.Vacchiano, N.Salvarani, A.Alogna,P.Carullo, G.B. Ramirez-Rodríguez, T.Patrício, L. Degli Esposti, F. Rossi, F. Ravanetti, S.Pinelli, R.Alinovi, M.Erreni, S. Rossi, G.Condorelli, H.Post, A.Tampieri, & D.Catalucci*. Inhalation of peptide-loaded nanoparticles improves heart failure. Science Translational Medicine, Jan 17;10(424). pii: eaan6205 (2018). Barili V, Fisicaro P, Montanini B, Acerbi G, Filippi A, Forleo G, Romualdi C, Ferracin M, Guerrieri F, Pedrazzi G, Boni C, Rossi M, Vecchi A, Penna A, Zecca A, Mori C, Orlandini A, Negri E, Pesci M, Massari M, Missale G, Levrero M, Ottonello S, Ferrari C. Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection. Nat Commun. 2020 Jan 30;11(1):604. Fisicaro P, Barili V, Montanini B, Acerbi G, Ferracin M, Guerrieri F, Salerno D, Boni C, Massari M, Cavallo MC, Grossi G, Giuberti T, Lampertico P, Missale G, Levrero M, Ottonello S, Ferrari C. Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B. Nat Med. 2017 Mar;23(3):327-336. Foresti R, Rossi S, Pinelli S, Alinovi R, Sciancalepore C, Delmonte N, Selleri S, Caffarra C, Raposio E, Macaluso G, Macaluso C, Freyrie A, Miragoli M, Perini P. In-vivo vascular application via ultra-fast bioprinting for future 5D personalised nanomedicine. Sci Rep. 2020 Feb 21;10(1):3205. doi: 10.1038/s41598-020-60196-y.
Post-CCT fellowship in the Advanced Ventricular Arrhythmia Training and Research (AVATAR) program at St. George’s Hospital, London, UK Full timeWe are recruiting for a fully funded, salaried post-Certificate of Completion of Training (CCT) level, or EU-equivalent, clinical fellowship in Ventricular Arrhythmias at St. George’s Hospital, London, UK. The successful candidate will have the opportunity to gain first-hand operator experience in mapping and ablation of ventricular arrhythmias in a busy tertiary cardiology centre, with quaternary referrals for ventricular arrhythmias. The fellow can expect to gain experience in mapping and ablation of ventricular arrhythmias, including epicardial-endocardial, in all substrates. The minimum duration is 12 months, starting October 2023.The candidate, along with the Cardiac Electrophysiology Consultants, will be involved as an Investigator in research projects on ventricular arrhythmias and in the education program for allied professionals as well as providing bedside teaching to the medical students and junior doctors attached to the Arrhythmia Service. The experience gained during this fellowship will provide an excellent foundation for a Consultant career in complex arrhythmia management.This post is appropriate for a senior Cardiac Electrophysiology trainee committed to a career in ablation, with an interest in clinical research and Arrhythmia Service development. The post holder will have completed their General Professional Training in the UK, EU, the USA, or have equivalent experience within a recognized healthcare system and will hold full MRCP or equivalent. Applicants will be expected to be independent in SVT and AF ablation, brady- and complex devices and ideally have some preliminary experience of mapping within the ventricles.Fellows enrolled in the AVATAR program would be expected to be in the lab in all VA ablations carried out as part of the VT ablation program as well as on device, simple and complex ablation lists, cover a weekly Arrhythmia Clinic under Dr Saba’s supervision and be competent to undertake on-call duties at Consultant level. The fellow will be responsible for the Ventricular Arrhythmia database during their tenure.We have a busy Arrhythmia Service, carrying out over 400 AF ablation cases and up to 100 VA ablations per year, in addition to a high volume of simple ablation procedures, and simple and complex device implantations.St George’s Healthcare NHS Trust is the main Teaching Hospital for St George’s, University of London and plays an important role in medical student teaching. The Cardiology Clinical Academic Group has been created to execute a shared strategic partnership between St George’s Hospital NHS Foundation Trust and St George’s, University of London.Interested applicants should contact Dr Magdi Saba, with CV attached, via email at msaba@sgul.ac.uk by February 17th, 2023. Interviews will be held in late February 2023.